Sulfamethoxazole And Trimethoprim Injection, Solution, Concentrate
Product Images NDC 0703-9514

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sulfamethoxazole And Trimethoprim (NDC 0703-9514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of Sulfamethoxazole, one of the active ingredients in Sulfamethoxazole and Trimethoprim injection solution concentrate.*

FDA Label Image

2 (Image 2)

Chemical structure diagram of Sulfamethoxazole, one of the active ingredients in Sulfamethoxazole and Trimethoprim injection solution concentrate by Teva Parenteral Medicines, Inc.*

FDA Label Image

Nova-image (Image 3)

FDA Label Image

1 (Image 4)

Packaging label for Sulfamethoxazole and Trimethoprim Injection, USP, intravenous solution concentrate. The vial contains 80 mg/mL Sulfamethoxazole and 16 mg/mL Trimethoprim in a 10 mL multiple-dose vial. The label indicates it is for intravenous infusion only and must be diluted with 5% dextrose injection prior to administration. Labeler is Teva Parenteral Medicines, Inc., with branding from novaplus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.